Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.
eliglustat 84 MG Oral Capsule [Cerdelga]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Paris January 22, 2015 Sanofi and its subsidiary Genzyme announced today that the European Commission (EC) has granted marketing… Expand
Review
2015
Review
2015
Oral eliglustat (Cerdelga®) is approved in several countries for the long-term treatment of adults with Gaucher disease type 1… Expand
Review
2014
Review
2014
Eliglustat [Cerdelga™ (US, EU)], a small-molecule oral glucosylceramide analogue that inhibits the enzyme glucosylceramide… Expand